Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
April 13 2023 - 4:30PM
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company
that features personalized knee and hip replacement products,
announced today it will release its financial results for the first
quarter ended March 31, 2023, before the market opens on Monday,
May 8, 2023.
Mark Augusti, CEO, and Bob Howe, CFO, will host
a webcast and conference call at 8:30 a.m. Eastern Time to discuss
the financial results and provide a business update.
Earnings Call and Webcast
Details:
The webcast of the earnings call will be live
at: Link Directly to Webcast
To attend by telephone, please use the
information below for dial-in access.
- Date and Time: May 8, 2023 – 8:30 a.m. Eastern
Time
- Please register for the call. You can register any time
starting now through the call.
- Link to register: Registration Link
- Registration in advance is encouraged. As part of
the registration process, you can choose to be provided with the
dial-in and PIN or to use the automated “Call Me” feature.
Please visit the Investor Relations website at
ir.conformis.com on May 8, 2023, to view the earnings release prior
to the webcast and conference call.
The online archive of the webcast will be
available on the company’s website at ir.conformis.com for 30
days.
About Conformis, Inc.Founded in
2004, Conformis is a medical technology company focused on
advancing orthopedic patient care and creating a world without
joint pain. Its product portfolio is designed to maximize surgeon
and patient choice by offering fully personalized solutions through
its Image-to-Implant® Platinum Services℠ Program as well as
data-informed, standardized solutions that combine many benefits of
personalization with the convenience and flexibility of an
off-the-shelf system. Conformis’ sterile, just-in-time,
Surgery-in-a-Box™ delivery system is available with all of its
implants and personalized, single-use instruments. Conformis owns
or exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints. For more information, visit
www.conformis.com. To receive future press releases via e-mail
alerts, sign up at ir.conformis.com.
ContactInvestor Contact:Investor
Relationsir@conformis.com(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024